- Industry News
The EU Council adopted its negotiating position on the first major overhaul of pharmaceutical legislation since 2004. The package targets faster access, competitiveness and incentives (notably for antimicrobials), alongside obligations on supply continuity and environmental risk. Why it matters for API trade• Stronger expectations for shortage prevention plans and notification lead‑times.• Potential impact on data…
- Company News
Acetazolamide is a well-established carbonic anhydrase inhibitor widely used as an active pharmaceutical ingredient (API) in various therapeutic areas. At TCS GROUP, our acetazolamide offering meets high-purity standards, making it ideal for formulation into tablets, capsules, or parenteral systems. According to pharmacological data, acetazolamide functions by inhibiting the enzyme carbonic anhydrase, thereby reducing aqueous humor…
- Company News
Meet Us in CPHI (Frankfurt)
- Industry News
As the pharmaceutical sector accelerates into a post-pandemic era, the global API market is expected to reach unprecedented levels. Rising healthcare demands in emerging markets, the growth of biologics, and a strong generics pipeline are creating exciting opportunities for API manufacturers. However, challenges such as geopolitical uncertainty, stricter environmental regulations, and increased scrutiny from regulatory…
- Industry News
In the current pharmaceutical ecosystem, a delayed delivery or compromised batch can cost millions and damage credibility. This is why supply-chain reliability has become a critical driver of success rather than a back-end function. Companies that collaborate with consistent API partners enjoy guaranteed production timelines, predictable costs, and smoother regulatory processes. Such reliability allows marketing…